Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients

American Journal of Surgery

Volumn 194, Issue 3, 2007, Pages 367-374

  Yellin, Albert E ^a   Johnson, Jeffrey ^a   Higareda, Iliana ^b   Congeni, Blaise L ^c   Arrieta, Antonio C ^d   Fernsler, Doreen ^e   West, Joseph ^e   Gesser, Richard ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^c AKRON CHILDREN'S HOSPITAL   (United States)

^d CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Acute pelvic infection; Ertapenem; Intra abdominal; Pediatric

Indexed keywords

CARBAPENEM DERIVATIVE; ERTAPENEM; TIMENTIN;

ABDOMINAL INFECTION; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INJECTION SITE BURNING; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE WARMTH; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PELVIC INFLAMMATORY DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SCHOOL CHILD; SIDE EFFECT; THROMBOCYTE COUNT; VAGINA CANDIDIASIS;

ABDOMINAL CAVITY; ACUTE DISEASE; ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAMS; CHILD; CHILD, PRESCHOOL; CLAVULANIC ACIDS; FEMALE; HUMANS; MALE; PELVIS; PROSPECTIVE STUDIES; TICARCILLIN;

EID: 34547652471     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.01.023     Document Type: Article

References (14)

1. Dougherty S.H., Sirinek K.R., Schauer P.R., et al. Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intraabdominal infections in pediatric and adult patients. Am Surg 61 (1995) 297-303
2. th ed. (1996), Appleton & Lange, Stamford, CT 1105-1107
3. Hemsell D.L., Solomkin J.S., Sweet R., et al. Evaluation of new anti-infective drugs for the treatment of acute pelvic infections in hospitalized women. Clin Infect Dis 15 suppl 1 (1992) S43-S52
4. Solomkin J.S., Yellin A.E., Rotstein O.D., et al. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg 237 (2003) 235-245
5. Yellin A.E., Hassett J.M., Fernandez A., et al. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intraabdominal infections in adults. Int J Antimicrob Agents 20 (2002) 165-173
6. Roy S., Higareda I., Angel-Muller E., et al. Ertapenem once a day versus piperacillin/tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study. Infect Dis Obstet Gynecol 11 (2003) 27-37
7. Zhanel G.G., Johanson C., Embil J.M., et al. Ertapenem: review of a new carbapenem. Expert Rev Anti Infect Ther 3 (2005) 23-39
8. Keating G.M., and Perry C.M. Ertapenem. A review of its use in treatment of bacterial infections. Drugs 65 (2005) 2151-2178
9. Shah P.M., and Issacs R.D. Ertapenem, the first of a new group of carbapenems. J Antimicrob Chemother 52 (2003) 538-542
10. Mistry G., Blumer J., Topelburg S., et al. Single dose pharmacokinetics (PK) of ertapenem (ERT) in pediatric patients (2005) Poster presented at the 45th Annual International Conference on Antimicrobial Agents and Chemotherapy, December 17, Washington, DC
11. Beam Jr. T.R., Gilbert D.N., and Kunin C.M. General guidelines for the clinical evaluation of anti-infective drug products. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 15 suppl 1 (1992) S5-S12
12. Solomkin J.S., Hemsell D.L., Sweet R., et al. Evaluation of new anti-infective drugs for the treatment of intraabdominal infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 15 suppl 1 (1992) S33-S42
13. Solomkin J.S., Mazuski J.E., Baron E.J., et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 37 (2003) 997-1005
14. Mazuski J.E., Sawyer R.G., Nathens A.B., et al. The Surgical Infection Society Guidelines on antimicrobial therapy for treatment of complicated intra-abdominal infections: an executive summary. Surg Infect 3 (2002) 161-173